404 related articles for article (PubMed ID: 16110011)
21. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
[TBL] [Abstract][Full Text] [Related]
22. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
23. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.
Mabbott DJ; Spiegler BJ; Greenberg ML; Rutka JT; Hyder DJ; Bouffet E
J Clin Oncol; 2005 Apr; 23(10):2256-63. PubMed ID: 15800316
[TBL] [Abstract][Full Text] [Related]
24. Cognitive consequences of the treatment of medulloblastoma among children.
Saury JM; Emanuelson I
Pediatr Neurol; 2011 Jan; 44(1):21-30. PubMed ID: 21147383
[TBL] [Abstract][Full Text] [Related]
25. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
26. Vertebral body growth after craniospinal irradiation.
Hartley KA; Li C; Laningham FH; Krasin MJ; Xiong X; Merchant TE
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1343-9. PubMed ID: 18164830
[TBL] [Abstract][Full Text] [Related]
27. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma.
Palmer SL; Gajjar A; Reddick WE; Glass JO; Kun LE; Wu S; Xiong X; Mulhern RK
Neuropsychology; 2003 Oct; 17(4):548-55. PubMed ID: 14599268
[TBL] [Abstract][Full Text] [Related]
28. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.
Palmer SL; Hassall T; Evankovich K; Mabbott DJ; Bonner M; Deluca C; Cohn R; Fisher MJ; Morris EB; Broniscer A; Gajjar A
Neuro Oncol; 2010 Dec; 12(12):1311-7. PubMed ID: 20713408
[TBL] [Abstract][Full Text] [Related]
29. Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy.
Gupta T; Jalali R; Goswami S; Nair V; Moiyadi A; Epari S; Sarin R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1534-40. PubMed ID: 22342098
[TBL] [Abstract][Full Text] [Related]
30. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
[TBL] [Abstract][Full Text] [Related]
31. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
32. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
33. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.
Lew SM; Morgan JN; Psaty E; Lefton DR; Allen JC; Abbott R
J Neurosurg; 2006 Feb; 104(2 Suppl):103-7. PubMed ID: 16506497
[TBL] [Abstract][Full Text] [Related]
34. Outcome of medulloblastoma in children: long-term complications and quality of life.
Ribi K; Relly C; Landolt MA; Alber FD; Boltshauser E; Grotzer MA
Neuropediatrics; 2005 Dec; 36(6):357-65. PubMed ID: 16429375
[TBL] [Abstract][Full Text] [Related]
35. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
36. Change in neurocognitive functioning after treatment with cranial radiation in childhood.
Spiegler BJ; Bouffet E; Greenberg ML; Rutka JT; Mabbott DJ
J Clin Oncol; 2004 Feb; 22(4):706-13. PubMed ID: 14966095
[TBL] [Abstract][Full Text] [Related]
37. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.
Carrie C; Muracciole X; Gomez F; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Soum F; Baron MH; Clavere P; Chapet S; Gaci Z; Kolodie H; Maingon P; Vie B; Bernier V; Alapetite C; Hoffstetter S; Grill J; Lafay F;
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):711-6. PubMed ID: 15927408
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE
J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884
[TBL] [Abstract][Full Text] [Related]
39. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.
Sands SA; Oberg JA; Gardner SL; Whiteley JA; Glade-Bender JL; Finlay JL
Pediatr Blood Cancer; 2010 Mar; 54(3):429-36. PubMed ID: 20052775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
